期刊文献+

非瓣膜性心房颤动患者并发缺血性脑卒中的多因素分析 被引量:5

The risk factors analysis for ischemic stroke in chinese patients with nonvalvular atrial fibrillation
下载PDF
导出
摘要 目的 探索非瓣膜性心房颤动患者并发缺血性脑卒中的危险因素及保护因素。方法 对入选的901例非瓣膜性心房颤动患者进行随访3年,收集其一般状况、相关疾病病史和服用药物的临床资料,按照随访期间是否发生缺血性脑卒中分为卒中组(n=39)和非卒中组(n=862),并应用多因素Logistic回归分析其发生卒中的危险因素及保护因素。结果 发生缺血性脑卒中的危险因素有年龄(OR=1.087,95%CI:0.240-1.315)、心力衰竭病史(OR=2.245,95%CI:1.033-4.880)、缺血性卒中或短暂性脑缺血发作病史(OR=5.265,95%CI:2.545-10.889)、其他全身性栓塞病史(OR=5.034,95%CI:1.307-19.386)、利尿剂的应用(OR=3.505,95%CI:1.715-7.165);保护因素有血管紧张素受体阻滞剂(ARB)的应用(P〈0.05,OR=0.316,95%CI:0.122-0.815)。结论 年龄、心力衰竭、缺血性卒中或短暂性脑缺血发作、其他全身性栓塞病史,以及利尿剂的应用,是非瓣膜性心房颤动患者并发缺血性脑卒中的独立危险因素,而ARB的应用是保护因素。 Objective To investigate the risk factors of ischemic stroke in Chinese patients with nonvalvular at- rial fibrillation. Methods According to the occurrence of ischemic stroke in three-years follow-up period among 901 pa- tients with nonvalvular atrial fibrillation were divided into two groups : Stroke group ( n = 39) and Non - Stroke group ( n = 862). Data for demographics, medical histories and complications, concurrent medications were recorded. Results the risk factors of ischemic stroke in patients with nonvalvular atrial fibrillation are age( OR = 1. 087,95% CI:O. 240 - 1.315 ), medical history of heart failure ( OR = 2.245,95 % CI: 1. 033 - 4. 880), ischemic stroke or TIA ( OR = 5. 265, 95% CI:2. 545 - 10.889), other systemic embolism( OR = 5. 034,95% CI: 1. 307 - 19. 386) and diuretic ( OR = 3. 505, 95% CI: 1. 715 - 7. 165). While application of ARB( OR = 0. 316,95% CI:0. 122 - 0. 815 ) was the protective factor. Conclusion Age, medical history of heart failure,ischemic stroke or TIA,other systemic embolism and diuretic are the risk factors of ischemic stroke in patients with nonvalvular atrial fibrillation,while protective factor is ARB.
出处 《中国临床保健杂志》 CAS 2016年第1期4-7,共4页 Chinese Journal of Clinical Healthcare
基金 解放军总后勤部保健专项科研课题(14BJZ08)
关键词 心房颤动 卒中 危险因素 LOGISTIC模型 Atrial fibrillation Stroke Risk factors Logistic models
  • 相关文献

参考文献14

  • 1Tse HF, Wang Y J, Ahmed Ai-Abdullah M, et al. Stroke prevention in atrial fibrillation-an Asian stroke perspective [J]. Heart Rhythm,2013 ,10(7) :1082-1088.
  • 2Chugh SS,Hav-moeller R,Narayanan K, et al. Worldwide epidemiology of atrial fibrillation:a Global Burden of Dis- ease 2010 Study[ J ]. Circulation ,2014,129 (8) :837-847.
  • 3Camm AJ,Lip GY,De Caterina R,et al. 2012 focused up-date of the ESC guidelines for the management of atrial fi- brillation:an update of the 2010 ESC guidelines for the management of atrial fibrillation [ J ]. Eur Heart J, 2012, 33(21 ) :2719-2747.
  • 4De Caterina R, Husted S, Wallentin L, et al. Vitamin K antagonists in heart disease:current status and perspec- tives (Section Ⅲ). Position paper of the ESC working group on thrombosis - task force on anticoagulants in heart disease [ J ]. Thromb Haemost,2013,110 (6) : 1087-1107.
  • 5European Heart Rhythm Association. Guidelines for the management of atrial fibrillation:the task force for the management of atrial fibrillation of the European Society of Cardiology ( ESC ) [ J ]. Eur Heart J, 2010,31 ( 19 ) : 2369-2429.
  • 6Paciaroni M, Agnelli G, Ageno W, et al. Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention [ J ]. Atherosclerosis, 2010,212(2) :564-566.
  • 7Chien KL, Su TC, Hsu HC, et al. Atrial fibrillation preva- lence, incidence and risk of stroke and all-cause death a- mong Chinese [ J ]. Int J Cardio1,2010,139 ( 2 ) : 173-180.
  • 8Adams HP. Clopidogrel plus aspirin versus oral anticoagu- lation for atrial fibrillation in the atrial fibrillation [ J ]. Curr Neurol Neurosci Rep,2007,7( 1 ) :5-7.
  • 9Fauchier L, Pierre B, de Labriolle A, et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analy- sis of randomized controlled trials [ J ]. J Am Coll Cardiol, 2008,51 (8) : 828-835.
  • 10Sherman DG, Kim SG, Boop BS, et al. Occurrence and characteristics of stroke events in the atrial fibrillation fol- low-up investigation of sinus rhythm management study [J]. Arch Intern Med,2005,165(10) :1185-1191.

共引文献36

同被引文献54

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部